Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
2.
Br J Dermatol ; 148(5): 1001-9, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12786833

RESUMO

Background Ultraviolet radiation (UVR), a ubiquitous environmental genotoxin for the skin, produces DNA damage. The trace element selenium induces synthesis of the glutathione peroxidase and thioredoxin reductase enzyme families. These selenoenzymes detoxify a range of toxic compounds generated by free radicals. Objectives To assess the effects of pretreatment of primary human keratinocytes with selenium on UVR-induced DNA damage. Methods Cells were irradiated with UVR from FS-20 lamps and were subjected to comet assay. Results Comet tail length due to UVR-induced T4 endonuclease V-sensitive sites (caused by cyclopyrimidine dimers, CPDs) increased to 35 +/- 4.5 microm (mean +/- SD) immediately after irradiation (time 0 h, 100%). After 4 h, 68% of the damage remained and after 24 h, 23% of the damage was still present. Treatment with up to 200 nmol L-1 selenomethionine or 50 nmol L-1 sodium selenite had no effect on CPD formation or rates of repair, or on the number of excision repair sites as measured by cytosine arabino furanoside and hydroxyurea treatment. However, selenite and selenomethionine protected against oxidative damage to DNA as measured by formation of formamidopyrimidine (FaPy) glycosylase-sensitive sites, which are indicative of 8-hydroxy-2-deoxyguanosine photoproduct formation. In this assay, irradiation of keratinocytes increased mean +/- SD glycosylase-specific comet tail length from 5 +/- 1.5 microm to 19 +/- 3.3 microm. Preincubation for 18 h with 50 nmol L-1 selenite abolished the UVR-induced increase in comet length. Preincubation with 200 nmol L-1 selenomethionine was similarly protective. Conclusions Selenite and selenomethionine protect keratinocytes from UVR-induced oxidative damage, but not from formation of UVR-induced excision repair sites.


Assuntos
Dano ao DNA/efeitos dos fármacos , Desoxiguanosina/análogos & derivados , Queratinócitos/efeitos dos fármacos , Queratinócitos/efeitos da radiação , Selênio/farmacologia , Raios Ultravioleta/efeitos adversos , 8-Hidroxi-2'-Desoxiguanosina , Análise de Variância , Células Cultivadas , Ensaio Cometa , Reparo do DNA , Desoxiguanosina/análise , Humanos , Queratinócitos/metabolismo , Dímeros de Pirimidina/análise , Selenometionina/farmacologia , Selenito de Sódio/farmacologia
3.
Br J Dermatol ; 146(3): 485-9, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11952550

RESUMO

BACKGROUND: Selenium is an essential trace nutrient necessary for the normal function of the immune system. Selenium compounds protect mice against ultraviolet (UV) B-induced tumours, probably by preventing oxidative damage to the host skin cells and to the host immune system. One possible mechanism of protection is that selenium can prevent oxidative stress-induced release of cytokines such as interleukin (IL)-10, which could suppress cell-mediated immunity. OBJECTIVES: To determine whether selenium compounds can inhibit UVB induction of IL-10 protein in murine keratinocytes. METHODS: The murine keratinocyte cell line PAM 212 was treated with or without selenomethionine (50-200 nmol L-1) or sodium selenite (1-50 nmol L(-1)) for 24 h before exposure to 200 J m(-2) UVB. The cells were stained with an antibody to IL-10, 24 h after irradiation. RESULTS: Preincubation with both selenium compounds inhibited UVB induction of IL-10 immunostaining, although selenomethionine was more effective. Pretreatment with 200 nmol L(-1) selenomethionine decreased IL-10 immunostaining to levels seen in the unirradiated controls. CONCLUSIONS: The protective effects of selenium against UVB-induced skin cancer in murine models may result, in part, from its ability to inhibit release of cytokines that are capable of suppressing cell-mediated immunity.


Assuntos
Interleucina-10/imunologia , Queratinócitos/imunologia , Queratinócitos/efeitos da radiação , Compostos de Selênio/uso terapêutico , Raios Ultravioleta/efeitos adversos , Animais , Linhagem Celular , Imunidade Celular/efeitos dos fármacos , Imuno-Histoquímica , Camundongos , Selenometionina/uso terapêutico , Selenito de Sódio/uso terapêutico
4.
London; Blackwell Science; 2 ed; 1995. ix,316 p. ilus, tab, 25cm.
Monografia em Inglês | LILACS, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1086075
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...